{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:56:11Z","timestamp":1792515371746,"version":"4.5.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.kint.2017.04.048","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T01:01:30Z","timestamp":1503450090000},"page":"1058-1070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit?"],"prefix":"10.1016","volume":"92","author":[{"given":"Andrew","family":"Davenport","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Faisal","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banwari","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Jalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2017.04.048_bib1","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib2","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(56)90149-0","article-title":"Electrolyte and circulatory changes in terminal liver failure","volume":"271","author":"Hecker","year":"1956","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2017.04.048_bib3","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.kint.2017.04.048_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.gastro.2014.05.005","article-title":"Toward an improved definition of acute-on-chronic liver failure","volume":"147","author":"Jalan","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.kint.2017.04.048_bib5","doi-asserted-by":"crossref","first-page":"R227","DOI":"10.1186\/cc11882","article-title":"Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study","volume":"16","author":"Jalan","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.kint.2017.04.048_bib6","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.kint.2017.04.048_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrgastro.2015.174","article-title":"The evolving concept of acute kidney injury in patients with cirrhosis","volume":"12","author":"Wong","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib8","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.kint.2017.04.048_bib9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/gut.2010.236133","article-title":"Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.kint.2017.04.048_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib11","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","article-title":"Acute kidney injury in decompensated cirrhosis","volume":"62","author":"Tsien","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.kint.2017.04.048_bib13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A\u00a0modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib14","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1053\/j.gastro.2013.08.051","article-title":"New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection","volume":"145","author":"Wong","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.kint.2017.04.048_bib15","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/MCG.0b013e31822e8e12","article-title":"Acute kidney injury network criteria as a predictor of hospital mortality in cirrhotic patients with ascites","volume":"46","author":"de Carvalho","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.kint.2017.04.048_bib16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cgh.2016.09.156","article-title":"Validation of a Staging System for Acute Kidney Injury in Patients With Cirrhosis and Association With Acute-on-Chronic Liver Failure","volume":"15","author":"Huelin","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/MEG.0b013e328308bb9c","article-title":"Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality","volume":"21","author":"Cholongitas","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S1665-2681(19)31491-7","article-title":"Causes of renal failure in patients with decompensated cirrhosis and its impact in hospital mortality","volume":"11","author":"Carvalho","year":"2012","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5152\/tjg.2015.15169","article-title":"Incidence, causes, and outcomes of renal failure among cirrhotic patients","volume":"26","author":"Morsy","year":"2015","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.kint.2017.04.048_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/flgastro-2012-100291","article-title":"Acute kidney injury is independently associated with death in patients with cirrhosis","volume":"4","author":"Scott","year":"2013","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.kint.2017.04.048_bib21","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2011.10.016","article-title":"Renal failure and cirrhosis: a systematic review of mortality and prognosis","volume":"56","author":"Fede","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib23","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3350\/cmh.2014.20.2.185","article-title":"Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal","volume":"20","author":"Choi","year":"2014","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib25","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.3748\/wjg.v18.i24.3035","article-title":"Kidneys in chronic liver diseases","volume":"18","author":"Hartleb","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.kint.2017.04.048_bib26","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/ndt\/gfm914","article-title":"Outcome predictors and new score of critically ill cirrhotic patients with acute renal failure","volume":"23","author":"Fang","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2017.04.048_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.14218\/JCTH.2015.00015","article-title":"Acute Kidney Injury in Patients with Cirrhosis","volume":"3","author":"Russ","year":"2015","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib28","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJM197311292892201","article-title":"Recovery from \u201chepatorenal syndrome\u201d after orthotopic liver transplantation","volume":"289","author":"Iwatsuki","year":"1973","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.04.048_bib29","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM196906192802501","article-title":"Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease","volume":"280","author":"Koppel","year":"1969","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.04.048_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.04.048_bib31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jhep.2010.08.001","article-title":"Renal and circulatory dysfunction in cirrhosis: current management and future perspectives","volume":"53","author":"Sola","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib32","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jhep.2016.07.003","article-title":"Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis","volume":"65","author":"Sola","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib33","doi-asserted-by":"crossref","first-page":"e0138264","DOI":"10.1371\/journal.pone.0138264","article-title":"Copeptin as an Indicator of Hemodynamic Derangement and Prognosis in Liver Cirrhosis","volume":"10","author":"Kerbert","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.kint.2017.04.048_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9343(70)80073-0","article-title":"Renal failure in the patient with cirrhosis. The role of active vasoconstriction","volume":"49","author":"Epstein","year":"1970","journal-title":"Am J Med"},{"key":"10.1016\/j.kint.2017.04.048_bib35","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/hep.1840200411","article-title":"Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index","volume":"20","author":"Maroto","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1159\/000363584","article-title":"A\u00a0pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements","volume":"39","author":"Mindikoglu","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.kint.2017.04.048_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.gastro.2007.10.055","article-title":"Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis","volume":"134","author":"Stadlbauer","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.kint.2017.04.048_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/039139880903200303","article-title":"Terlipressin for hepatorenal syndrome: A meta-analysis of randomized trials","volume":"32","author":"Fabrizi","year":"2009","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.kint.2017.04.048_bib39","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12876-015-0389-9","article-title":"Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis","volume":"15","author":"Salerno","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.kint.2017.04.048_bib40","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1365-2036.2006.03086.x","article-title":"Meta-analysis: terlipressin therapy for the hepatorenal syndrome","volume":"24","author":"Fabrizi","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.kint.2017.04.048_bib41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ki.2014.338","article-title":"Renal dysfunction in cirrhosis is not just a vasomotor nephropathy","volume":"87","author":"Adebayo","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.04.048_bib42","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2215\/CJN.03390412","article-title":"AKI in a patient with cirrhosis and ascites","volume":"7","author":"Davenport","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.04.048_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/gut.2009.180570","article-title":"Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.kint.2017.04.048_bib44","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serste","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib45","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1053\/j.gastro.2014.03.005","article-title":"Nonselective beta blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"146","author":"Mandorfer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.kint.2017.04.048_bib46","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/hep.26535","article-title":"Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death","volume":"58","author":"Acevedo","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib47","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1478-3231.2011.02751.x","article-title":"Cardiac dysfunction in cirrhosis - does adrenal function play a role? A hypothesis","volume":"32","author":"Theocharidou","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.kint.2017.04.048_bib48","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-0036-1583194","article-title":"The Organs in Acute-on-Chronic Liver Failure","volume":"36","author":"Weichselbaum","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.kint.2017.04.048_bib49","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.510270507","article-title":"Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality","volume":"27","author":"Navasa","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib50","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1002\/hep.21920","article-title":"Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure","volume":"46","author":"Thabut","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib51","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/gutjnl-2014-307526","article-title":"Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.kint.2017.04.048_bib52","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1016\/j.jhep.2014.11.045","article-title":"Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis","volume":"62","author":"Arroyo","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib53","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib54","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1186\/cc11188","article-title":"Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"16","author":"Nadim","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.kint.2017.04.048_bib55","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2013.12.032","article-title":"Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis","volume":"60","author":"Rodriguez","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib56","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/hep.26687","article-title":"Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival","volume":"59","author":"Barreto","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib58","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure","volume":"64","author":"Claria","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib59","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1478-3231.2009.02182.x","article-title":"The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study","volume":"30","author":"Trawale","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.kint.2017.04.048_bib60","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/liv.12047","article-title":"Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis","volume":"33","author":"Shah","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.kint.2017.04.048_bib61","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2011.11.024","article-title":"Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression","volume":"56","author":"Shah","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib62","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1159\/000064280","article-title":"Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells","volume":"91","author":"Jo","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2017.04.048_bib63","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fernandez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.kint.2017.04.048_bib64","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1007\/s10620-016-4313-0","article-title":"Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis","volume":"61","author":"Dong","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.kint.2017.04.048_bib65","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/jgh.12070","article-title":"Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis","volume":"28","author":"Vlachogiannakos","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib66","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ki.2013.78","article-title":"Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction","volume":"84","author":"van Slambrouck","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.04.048_bib67","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2017.02.019","article-title":"NorUrsodeoxycholic acid ameliorates cholemic nephropathy in bile duct ligated mice","volume":"67","author":"Krones","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib68","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/liv.12559","article-title":"Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure","volume":"35","author":"Mehta","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.kint.2017.04.048_bib69","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/gut.40.5.664","article-title":"Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man?","volume":"40","author":"Jalan","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.kint.2017.04.048_bib70","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ndt\/gfr736","article-title":"Medical management of hepatorenal syndrome","volume":"27","author":"Davenport","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2017.04.048_bib71","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4254\/wjh.v5.i8.433","article-title":"Can non-invasive measurements aid clinical assessment of volume in patients with cirrhosis?","volume":"5","author":"Davenport","year":"2013","journal-title":"World J Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib72","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archinte.1994.00420020117013","article-title":"Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis","volume":"154","author":"Caregaro","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.kint.2017.04.048_bib73","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13054-016-1478-z","article-title":"Acute kidney injury 2016: diagnosis and diagnostic workup","volume":"20","author":"Ostermann","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.kint.2017.04.048_bib74","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/clinchem\/43.8.1342","article-title":"Creatinine measurement proficiency testing: assignment of matrix-adjusted ID GC-MS target values","volume":"43","author":"Carobene","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.kint.2017.04.048_bib75","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1373\/clinchem.2008.116863","article-title":"Prime time for enzymatic creatinine methods in pediatrics","volume":"55","author":"Cobbaert","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.kint.2017.04.048_bib76","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1373\/clinchem.2011.172288","article-title":"Specificity characteristics of 7 commercial creatinine measurement procedures by enzymatic and Jaffe method principles","volume":"58","author":"Greenberg","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.kint.2017.04.048_bib77","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0009-9120(78)90383-1","article-title":"Specific method for serum creatinine determination based on ion exchange chromatography and an automated alkaline picrate reaction \u2013 a proposed reference method","volume":"11","author":"Weatherburn","year":"1978","journal-title":"Clin Biochem"},{"key":"10.1016\/j.kint.2017.04.048_bib78","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/clinchem\/43.9.1738","article-title":"Interferences of o-raffinose cross-linked hemoglobin in three methods for serum creatinine","volume":"43","author":"Ali","year":"1997","journal-title":"Clinical Chem"},{"key":"10.1016\/j.kint.2017.04.048_bib79","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/clinchem\/23.7.1340","article-title":"Positive interference with the Jaffe reaction by cephalosporin antibiotics","volume":"23","author":"Swain","year":"1977","journal-title":"Clin Chem"},{"key":"10.1016\/j.kint.2017.04.048_bib80","first-page":"909","article-title":"The accuracy of creatinine methods based on the Jaffe reaction: a questionable matter","volume":"32","author":"Blijenberg","year":"1994","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1016\/j.kint.2017.04.048_bib81","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/000456320203900609","article-title":"Creatinine assays: time for action?","volume":"39","author":"Lawson","year":"2002","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.kint.2017.04.048_bib82","doi-asserted-by":"crossref","first-page":"297","DOI":"10.5858\/2005-129-297-CMSOTA","article-title":"Creatinine measurement: state of the art in accuracy and interlaboratory harmonization","volume":"129","author":"Miller","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.kint.2017.04.048_bib83","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1093\/ndt\/gfr354","article-title":"Pitfalls in assessing renal function in patients with cirrhosis\u2013potential inequity for access to treatment of hepatorenal failure and liver transplantation","volume":"26","author":"Davenport","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2017.04.048_bib84","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4254\/wjh.v6.i10.696","article-title":"Difficulties in diagnosing acute kidney injury post liver transplantation using serum creatinine based diagnostic criteria","volume":"6","author":"Agarwal","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib85","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1478-3231.2008.01783.x","article-title":"Interlaboratory variability in assessment of the model of end-stage liver disease score","volume":"28","author":"Lisman","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.kint.2017.04.048_bib86","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2215\/CJN.09430913","article-title":"Urinary biomarkers and progression of AKI in patients with cirrhosis","volume":"9","author":"Belcher","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.04.048_bib87","doi-asserted-by":"crossref","first-page":"708585","DOI":"10.1155\/2014\/708585","article-title":"Early trends in cystatin C and outcomes in patients with cirrhosis and acute kidney injury","volume":"2014","author":"Belcher","year":"2014","journal-title":"Int J Nephrol"},{"key":"10.1016\/j.kint.2017.04.048_bib88","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib89","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.kint.2017.04.048_bib90","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib91","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhep.2016.03.002","article-title":"Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis","volume":"65","author":"Ariza","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib92","doi-asserted-by":"crossref","first-page":"e0128145","DOI":"10.1371\/journal.pone.0128145","article-title":"Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis","volume":"10","author":"Ariza","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.kint.2017.04.048_bib93","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00134-014-3540-0","article-title":"Biomarkers for AKI improve clinical practice: no","volume":"41","author":"Ostermann","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.kint.2017.04.048_bib94","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0036-1583198","article-title":"Management of Acute-on-Chronic Liver Failure","volume":"36","author":"Durand","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.kint.2017.04.048_bib95","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1378\/chest.07-2331","article-title":"Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares","volume":"134","author":"Marik","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.kint.2017.04.048_bib96","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jama.2013.430","article-title":"Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis","volume":"309","author":"Zarychanski","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2017.04.048_bib97","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa040232","article-title":"A\u00a0comparison of albumin and saline for fluid resuscitation in the intensive care unit","volume":"350","author":"Finfer","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.04.048_bib98","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4254\/wjh.v8.i7.345","article-title":"Human albumin solution for patients with cirrhosis and acute on chronic liver failure: beyond simple volume expansion","volume":"8","author":"Valerio","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib99","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.04.048_bib100","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm.3516","article-title":"Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2","volume":"20","author":"O'Brien","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2017.04.048_bib101","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.kint.2016.03.025","article-title":"Renal blood flow and acute kidney injury in septic shock: an arduous conflict that smolders intrarenally?","volume":"90","author":"Honore","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.04.048_bib102","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.04.048_bib103","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib104","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Solanki","year":"2003","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib106","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","article-title":"Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome","volume":"53","author":"Neri","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.kint.2017.04.048_bib107","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Martin-Llahi","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.kint.2017.04.048_bib108","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.kint.2017.04.048_bib109","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.kint.2017.04.048_bib110","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib111","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib112","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jceh.2015.08.003","article-title":"Randomized Controlled Trial Comparing the Efficacy of Terlipressin and Albumin with a Combination of Concurrent Dopamine, Furosemide, and Albumin in Hepatorenal Syndrome","volume":"5","author":"Srivastava","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib113","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.kint.2017.04.048_bib114","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s00134-008-1253-y","article-title":"Renal resistive index and renal function before and after paracentesis in patients with hepatorenal syndrome and tense ascites","volume":"35","author":"Umgelter","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.kint.2017.04.048_bib115","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1053\/j.ajkd.2011.07.017","article-title":"Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials","volume":"58","author":"Velez","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.04.048_bib116","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib117","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib118","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1440-1746.2002.02816.x","article-title":"Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin: a retrospective analysis","volume":"17","author":"Colle","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib119","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.kint.2017.04.048_bib120","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib121","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/jhep.2002.34343","article-title":"Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study","volume":"36","author":"Duvoux","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2017.04.048_bib122","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib123","first-page":"15","article-title":"Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study","volume":"64","author":"Mulkay","year":"2001","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.kint.2017.04.048_bib124","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1159\/000355739","article-title":"Hepatorenal syndrome and novel advances in its management","volume":"37","author":"Fabrizi","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.kint.2017.04.048_bib125","doi-asserted-by":"crossref","first-page":"e107466","DOI":"10.1371\/journal.pone.0107466","article-title":"Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis","volume":"9","author":"Nassar Junior","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.kint.2017.04.048_bib126","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MEG.0000000000000537","article-title":"Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation","volume":"28","author":"Mattos","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib127","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2015.10.019","article-title":"Management of the critically ill patient with cirrhosis: a multidisciplinary perspective","volume":"64","author":"Nadim","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib128","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1053\/j.gastro.2016.04.020","article-title":"Management of Hepatorenal Syndrome in the Era of Acute-on-Chronic Liver Failure: Terlipressin and Beyond","volume":"150","author":"Gines","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.kint.2017.04.048_bib129","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5966\/sctm.2012-0034","article-title":"Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients","volume":"1","author":"Shi","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.kint.2017.04.048_bib130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure","volume":"142","author":"Garg","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.kint.2017.04.048_bib131","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000334149","article-title":"The challenges of providing renal replacement therapy in decompensated liver cirrhosis","volume":"33","author":"Gonwa","year":"2012","journal-title":"Blood Purif"},{"key":"10.1016\/j.kint.2017.04.048_bib132","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jcrc.2015.05.006","article-title":"Role of renal replacement therapy in patients with type 1 hepatorenal syndrome receiving combination treatment of vasoconstrictor plus albumin","volume":"30","author":"Zhang","year":"2015","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.kint.2017.04.048_bib133","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gut.2008.174615","article-title":"Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.kint.2017.04.048_bib134","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/TP.0b013e3181a4430b","article-title":"Outcome of patients with hepatorenal syndrome type 1 after liver transplantation: Hangzhou experience","volume":"87","author":"Xu","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.kint.2017.04.048_bib135","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","article-title":"Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study","volume":"40","author":"Restuccia","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.kint.2017.04.048_bib136","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lt.21149","article-title":"Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT)","volume":"13","author":"Ruiz","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.kint.2017.04.048_bib137","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.transproceed.2013.02.127","article-title":"Experience of combined liver-kidney transplantation for acute-on-chronic liver failure patients with renal dysfunction","volume":"45","author":"Xing","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.kint.2017.04.048_bib138","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.24049","article-title":"Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation","volume":"21","author":"Wong","year":"2015","journal-title":"Liver Transpl"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381730474X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S008525381730474X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T20:53:06Z","timestamp":1750798386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S008525381730474X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":138,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S008525381730474X"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2017.04.048","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit?","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2017.04.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}